
|Videos|February 10, 2022
Dr. Marks on how PSMA imaging is “opening doors” in prostate cancer
Author(s)Urology Times staff
“We call this a ‘disruptive innovation,’” says Leonard S. Marks, MD.
Advertisement
In this video, Leonard S. Marks, MD, explains how the Journal of Urology review on prostate-specific antigen membrane imaging for prostate cancer will affect urologists and patients alike. Marks is a deKernion Endowed Chair in Urology at the David Geffen School of Medicine at the University of California, Los Angeles.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves label changes for first batch of menopausal hormone therapy products
2
Urologist explains science behind HA penile injections
3
Dual AR blockade shows promise for treatment-naïve mHSPC
4
Pearls & Perspectives: Expanding Options in Male Incontinence, with Laura Horodyski, MD
5






